• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kalvista Pharmaceuticals Inc (NQ: KALV )

    11.28 +0.10 (+0.89%)
    Streaming Delayed Price Updated: 11:27 AM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Kalvista Pharmaceuticals Inc

    < Previous 1 2 3 Next >
    NVIDIA To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    KALV Stock Earnings: KalVista Pharma Misses EPS for Q4 2024
    KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the fourth quarter of 2024. 
    Via InvestorPlace
    Recap: KalVista Pharma Q3 Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Insiders Buying Dorian LPG And 2 Other Stocks
    Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades. 
    Via Benzinga
    KalVista Pharma: Q2 Earnings Insights
    Via Benzinga
    Recap: KalVista Pharma Q4 Earnings
    Via Benzinga
    Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    What's Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday?
    Results from KalVista Pharmaceuticals' Phase 3 KONFIDENT trial. Sebetralstat, an oral on-demand therapy, shows efficacy for hereditary angioedema. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Insiders Buying Monro And 3 Other Stocks
    Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. 
    Via Benzinga
    $10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying
    Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. 
    Via Benzinga
    Analyst Expectations for KalVista Pharma's Future
    Via Benzinga
    Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
    Although U.S. stocks closed higher on Monday, there were a few notable insider trades. 
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    $230M Bet On Talos Energy? Check Out These 4 Stocks Insiders Are Buying
    Although U.S. stocks closed higher on Friday, there were a few notable insider trades. 
    Via Benzinga
    Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks
    Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades. 
    Via Benzinga
    $6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
    Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades. 
    Via Benzinga
    Around $2.4M Bet On HighPeak Energy? Check Out These 4 Stocks Insiders Are Buying
    Although U.S. stocks closed lower on Friday, there were a few notable insider trades. 
    Via Benzinga
    KALV Stock Earnings: KalVista Pharma Misses EPS for Q2 2024
    KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    3 Micro-Cap Stocks That Could Be Moonshots
    If you are hungry for high-risk returns, then these micro-cap stocks to buy could be your winning ticket to future yields. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Gold Rises Over 1%; Elys Game Technology Shares Spike Higher
    U.S. stocks traded mixed toward the end of trading, with the Dow Jones trading slightly higher on Tuesday. 
    Via Benzinga
    Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Major Indexes Falter As Rocky Year Wraps Up
    Stocks are struggling to build on their morning gains as investors began to waver on the possibility of a 
    Via Talk Markets
    Dow Rises 100 Points; Crude Oil Rises Over 1%
    U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Tuesday. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.